Personalized immunotherapy is revolutionizing cancer treatment by tailoring therapies to individual patients' immune systems and tumor characteristics. This approach harnesses the body's immune response to specifically target and destroy cancer cells while minimizing damage to healthy tissue. By analyzing the genetic makeup of tumors and the immune profiles of patients, researchers can develop personalized treatments such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. These therapies offer the potential for more effective and durable responses compared to traditional treatments like chemotherapy and radiation. With ongoing advancements in technology and understanding of the immune system, personalized immunotherapy holds promise for improving outcomes and quality of life for cancer patients in the future.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States